GenSci145 as Monotherapy or in Combination Therapy, in Participants With PIK3CA-mutated, Locally Advanced or Metastatic Solid Tumors.

Clinical trial NCT07407504 · RECRUITING

Trial details

NCT number: NCT07407504
Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced or Metastatic Solid Tumors With PIK3CA-mutated

Start date: 2026-04-01
Primary completion: 2028-11-08
Enrollment: 186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.